Experimental and clinical possibilities of MR spectroscopy of the heart

Experimental and clinical possibilities of MR spectroscopy of the heart

Show other versions (1)

MR-spectroscopy of the heart is a relatively new technique for the study of various aspects of cardiac metabolism. The majority of results has so far been obtained with the isolated perfused heart. Here, 31P-MR spectroscopy can be employed to measure high-energy phosphate metabolism and intracellula...

Full description

Bibliographic Details
Main Authors:	Neubauer, S, Ertl, G, Krahe, T, Schindler, R, Hillenbrand, H, Lackner, K, Kochsiek, K
Format:	Journal article
Language:	German
Published:	1991

Similar Items

[Experimental and clinical possibilities of MR spectroscopy of the heart]
by: Neubauer, S, et al.
Published: (1991)

Cardiac 31P-MR-spectroscopy in myocardial insufficiency
by: Krahe, T, et al.
Published: (1993)

[31P-cardio-MR-spectroscopy in myocardial insufficiency]
by: Krahe, T, et al.
Published: (1993)

[Magnetic resonance spectroscopy of the heart. Its clinical importance]
by: Neubauer, S, et al.
Published: (1993)

[In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results]
by: Krahe, T, et al.
Published: (1991)

In vivo 31P cardiac nuclear magnetic resonance spectroscopy. Methods and first clinical results
by: Krahe, T, et al.
Published: (1991)

Computed tomography and magnetic resonance tomography in cases of coronary heart disease
by: Lackner, K, et al.
Published: (1990)

[Computed tomography and magnetic resonance tomography in cases of coronary heart disease]
by: Lackner, K, et al.
Published: (1990)

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: Altered cardiac high-energy phosphate metabolism in heart failure
by: Neubauer, S, et al.
Published: (1992)

[The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium]
by: Schindler, R, et al.
Published: (1992)

Direct measurements of relaxation times of phosphorus metabolites in the human myocardium
by: Schindler, R, et al.
Published: (1992)

[Clinical relevance of MR spectroscopy of the heart]
by: Neubauer, S
Published: (2000)

MR spectroscopy in heart failure--clinical and experimental findings.
by: Ten Hove, M, et al.
Published: (2007)

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
by: Neubauer, S, et al.
Published: (1992)

Magnetic resonance imaging of the heart
by: Neubauer, S, et al.
Published: (1993)

Indications for cardio-MRT
by: Lackner, K, et al.
Published: (1990)

[Indications for cardio-MRT]
by: Lackner, K, et al.
Published: (1990)

MR spectroscopy in heart failure.
by: Holloway, C, et al.
Published: (2011)

[Possibilities of ACE inhibitor therapy in acute myocardial ischemia]
by: Ertl, G, et al.
Published: (1991)

Possibilities of ACE inhibitor therapy in acute myocardial ischemia
by: Ertl, G, et al.
Published: (1991)

[Stepwise diagnosis of heart failure]
by: Neubauer, S, et al.
Published: (1993)

Staged diagnosis in heart failure
by: Neubauer, S, et al.
Published: (1993)

Imaging methods in cardiology: Acute and chronic heart failure
by: Neubauer, S, et al.
Published: (1994)

[Imaging methods in cardiology. Heart failure (acute, chronic)]
by: Neubauer, S, et al.
Published: (1994)

Effects of endothelin-1 in isolated perfused rat heart.
by: Neubauer, S, et al.
Published: (1990)

Clinical cardiac magnetic resonance spectroscopy--present state and future directions.
by: Neubauer, S, et al.
Published: (1998)

Deterioration of metabolic coronary regulation in hemorrhagic shock. Role of hypoxia and the renin-angiotensin system.
by: Ertl, G, et al.
Published: (1985)

Is MR spectroscopy of the heart ready for humans?
by: Holloway, C, et al.
Published: (2010)

Direct measurement of spin-lattice relaxation times of phosphorus metabolites in human myocardium.
by: Neubauer, S, et al.
Published: (1992)

Effects of endothelin-1 in the isolated heart under ischemic and cardioplegic conditions.
by: Neubauer, S, et al.
Published: (1990)

[Cardiac energy metabolism in heart valve diseases with 31P MR spectroscopy]
by: Beer, M, et al.
Published: (2000)

Clinical studies with vasodilators in heart failure
by: Ertl, G, et al.
Published: (1992)

Human cardiac MR spectroscopy--clinical methods and applications.
by: Beer, M, et al.
Published: (1998)

Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
by: Neubauer, S, et al.
Published: (1997)

[Indications for ACE inhibitors in the postinfarct period]
by: Ertl, G, et al.
Published: (1994)

Indication of ACE-inhibitors post-myocardial infarction
by: Ertl, G, et al.
Published: (1994)

Effect of mediators on coronary circulation.
by: Ertl, G, et al.
Published: (1991)

[31P-MR spectroscopy of all regions of the human heart at 1.5 T with acquisition-weighted chemical shift imaging]
by: Köstler, H, et al.
Published: (2001)

Advances in human cardiac 31P-MR spectroscopy: SLOOP and clinical applications.
by: von Kienlin, M, et al.
Published: (2001)

[MR spectroscopy in brain tumors]
by: Papanagiotou, P, et al.
Published: (2007)